Mifamurtide sodium

• CAT Number: I032273
• CAS Number: 90825-43-7
• Molecular Formula: C59H108N6NaO19P
• Molecular Weight: 1259.48
• Purity: ≥95%
• Synonyms: sodium;2-[[(2S)-2-[[(4R)-4-[[(2S)-2-[[(2R)-2-[(2R,3R,4R,5R)-2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]propanoyl]amino]ethyl [(2R)-2,3-di(hexadecanoyloxy)propyl] phosphate
• InChI: InChI=1S/C59H109N6O19P.Na/c1-7-9-11-13-15-17-19-21-23-25-27-29-31-33-52(71)80-41-47(84-53(72)34-32-30-28-26-24-22-20-18-16-14-12-10-8-2)42-82-85(78,79)81-38-37-61-57(75)43(3)62-51(70)36-35-48(56(60)74)65-58(76)44(4)63-59(77)45(5)83-55(54(73)50(69)40-67)49(39-66)64-46(6)68;/h39,43-45,47-50,54-55,67,69,73H,7-38,40-42H2,1-6H3,(H2,60,74)(H,61,75)(H,62,70)(H,63,77)(H,64,68)(H,65,76)(H,78,79);/q;+1/p-1/t43-,44-,45+,47+,48+,49-,50+,54+,55+;/m0./s1
• InChIKey: LRSAONQAUPMYDK-XNLRRNFISA-M
• SMILES: CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)[C@H](C)NC(=O)CC[C@H](C(=O)N)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]([C@H](C=O)NC(=O)C)[C@@H]([C@@H](CO)O)O)OC(=O)CCCCCCCCCCCCCCC.[Na+]

Mifamurtide sodium（Cat No.:I032273）is the sodium salt form of mifamurtide, a synthetic analog of muramyl dipeptide that activates the innate immune system via the NOD2 receptor. It stimulates monocytes and macrophages, promoting the release of pro-inflammatory cytokines and enhancing the body’s immune response against tumors. Mifamurtide sodium is primarily used as an adjunct treatment for osteosarcoma in children and young adults, helping to reduce metastatic progression after standard chemotherapy. The sodium salt formulation improves solubility and injectability, making it suitable for clinical administration in cancer immunotherapy protocols.